Tags & Categorías

Researchers Report a Successful Switch and Suggest That Patient Education Played a Role

The switch included patients with rheumatoid arthritis and psoriatic arthritis who were treated at a single center in Amsterdam, the Netherlands.

La FDA trabaja en un plan para potenciar el desarrollo de biosimilares

Ha presentado una guía que incluye las pautas para acreditar biológicos como biosimilar al fármaco de referencia

Biocon to Benefit From Global Sales of Mylan's Adalimumab Biosimilar, Hulio

Biosimilar developer Biocon said this week that it will share in the global profits of Hulio, an adalimumab biosimilar referencing Humira, that is lic...

Castilla-La Mancha fue la comunidad autónoma con mayor penetración de medicamentos biosimilares en h...

Castilla-La Mancha fue la comunidad autónoma con mayor penetración de medicamentos biosimilares en hospitales en el periodo enero-septiembre del añ...

Eye on Pharma: Fresenius Kabi Launches Biosimilar Adalimumab, Idacio

Fresenius Kabi, maker of the EU-authorized biosimilar adalimumab, Idacio, has launched its product in Germany. Fresenius Kabi has made the biosimilar ...

Sandoz enters agreement for proposed trastuzumab biosimilar

Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar.

Navarra prevé ahorrar diez millones en gasto farmacéutico con el uso de biosimilares

El Servicio Navarro de Salud confía en reducir el gasto farmacéutico anual en los hospitales públicos mediante la compra centralizada.

CHMP Issues Positive Recommendation for Juta Pharma's Pegfilgrastim Biosimilar

Last Friday, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Juta Pharma’s p...

Biosimilar Filgrastim Similar to Reference Product When Used in NSCLC

New data from a subset analysis of the MONITOR‐GCSF, a multicenter study from Europe, show that biosimilar filgrastim has similar effectiveness and...

PBM Says Its Biosimilars Strategy Led to 86% Use of Biosimilar Infliximab

Magellan Rx Management, a pharmacy benefit manager (PBM), said today that its biosimilar management program has resulted in strong biosimilar uptake a...